Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

Keytruda claims first place in bladder cancer race

Keytruda claims first place in bladder cancer race Keytruda gets the new indication ahead of rivals in the checkpoint inhibitor class, including Bristol-Myers Squibb’s Opdivo (nivolumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab) that are

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer

Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer Merck’s Keytruda (pembrolizumab), Bristol-Myers Squibb’s Opdivo (nivolumab), Roche’s Tecentriq (atezolizumab) and AstraZeneca’s Imfinzi (durvalumab) are all approved for use in bladder cancer, albeit in differing settings.

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus GSK can't catch up with immunotherapy leaders, such as Merck &Co’s Keytruda and Bristol-Myers Squibb’s Opdivo, but its R&D chief Hal Barron (pictured right) has still

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis year – it’s second biggest product after cancer immunotherapy Opdivo (nivolumab) – and added $3.4bn to Pfizer’s top line.

J&J taps TARIS Biomedical for novel bladder cancer technology

J&J taps TARIS Biomedical for novel bladder cancer technology Most other checkpoint inhibitors also have at least one of those indications on the label, including Roche’s Tecentriq (atezolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab).

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics